-
Thesis Defense: Kate Koch
Hemann lab I "Utilizing in vivo genome-wide crispr-cas9 screens in an immunocompetent mouse model of glioblastoma to identify novel tumor liabiliti- Thesis Defenses
Friday, Mar 1, 2024, 2:00PM03/01/2024 02:00 PM America/New_York Thesis Defense: Kate Koch Hemann lab I "Utilizing in vivo genome-wide crispr-cas9 screens in an immunocompetent mouse model of glioblastoma to identify novel tumor liabiliti Whitehead Institute Auditorium